Atlas Trials

Glucagon Modulation of Ghrelin Secretion

Clinical trial NCT00929812 · UNKNOWN

Trial details

NCT number
NCT00929812
Sponsor
Charite University, Berlin, Germany
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Healthy SubjectsObesityDiabetes Mellitus, Type 1
Start date
2006-06-01
Primary completion
2008-01-01
Enrollment
38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.